Literature DB >> 365283

Effects of sulphinpyrazone and aspirin on prostaglandin I2 (prostacyclin) synthesis by endothelial cells.

J L Gordon, J D Pearson.   

Abstract

Synthesis of prostaglandin I2, (PGI2, prostacyclin) by vascular endothelium (assayed by the ability of cultured endothelial cells to inhibit platelet aggregation) was inhibited by aspirin. At 100 mumol/l aspirin completely blocked measurable PGI2 production, but endothelial cells had substantially recovered their ability to synthesize PGI2 24 h after removal of the drug. In contrast, the effect of 1 mmol/l aspirin was still evident 24 h after drug withdrawal. Sulphinpyrazone also inhibited PGI2 synthesis, but was about 100 fold less potent than aspirin, and the effect of the drug was lost within 24 h of its addition, even when endothelial cells were left in contact with the drug during this period.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 365283      PMCID: PMC1668445          DOI: 10.1111/j.1476-5381.1978.tb17308.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  15 in total

1.  Aggregation of blood platelets by adenosine diphosphate and its reversal.

Authors:  G V BORN
Journal:  Nature       Date:  1962-06-09       Impact factor: 49.962

2.  Cultured human skin fibroblasts and arterial cells produce a labile platelet-inhibitory prostaglandin.

Authors:  N L Baenziger; M J Dillender; P W Majerus
Journal:  Biochem Biophys Res Commun       Date:  1977-09-09       Impact factor: 3.575

3.  Localisation and stimulation of prostacyclin production in vascular cells.

Authors:  D E MacIntyre; J D Pearson; J L Gordon
Journal:  Nature       Date:  1978-02-09       Impact factor: 49.962

4.  Acetylation of prostaglandin synthase by aspirin.

Authors:  G J Roth; N Stanford; P W Majerus
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

5.  An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation.

Authors:  S Moncada; R Gryglewski; S Bunting; J R Vane
Journal:  Nature       Date:  1976-10-21       Impact factor: 49.962

6.  Modulation of human platelet adenylate cyclase by prostacyclin (PGX).

Authors:  R R Gorman; S Bunting; O V Miller
Journal:  Prostaglandins       Date:  1977-03

7.  Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium.

Authors:  S Moncada; A G Herman; E A Higgs; J R Vane
Journal:  Thromb Res       Date:  1977-09       Impact factor: 3.944

8.  Effects of sulfinpyrazone on platelet prostaglandin synthesis and platelet release of serotonin.

Authors:  M Ali; J W McDonald
Journal:  J Lab Clin Med       Date:  1977-04

9.  Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin.

Authors:  S Moncada; R Korbut
Journal:  Lancet       Date:  1978-06-17       Impact factor: 79.321

10.  Uptake and metabolism of adenosine by pig aortic endothelial and smooth-muscle cells in culture.

Authors:  J D Pearson; J S Carleton; A Hutchings; J L Gordon
Journal:  Biochem J       Date:  1978-02-15       Impact factor: 3.857

View more
  13 in total

Review 1.  Clinical pharmacokinetics and potentially important drug interactions of sulphinpyrazone.

Authors:  A K Pedersen; P Jakobsen; J P Kampmann; J M Hansen
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

Review 2.  The prostanoids in hemostasis and thrombosis: a review.

Authors:  J B Smith
Journal:  Am J Pathol       Date:  1980-06       Impact factor: 4.307

3.  The respiratory stress of playing the bagpipes [proceedings].

Authors:  T M Gibson
Journal:  J Physiol       Date:  1979-06       Impact factor: 5.182

4.  Measurement of local brain blood flow by hydrogen washout in the conscious rat [proceedings].

Authors:  D E Ray
Journal:  J Physiol       Date:  1979-06       Impact factor: 5.182

5.  Inhibition of prostacyclin by treatment of endothelium with aspirin. Correlation with platelet adherence.

Authors:  R L Czervionke; J B Smith; G L Fry; J C Hoak; D L Haycraft
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

6.  Effects of aspirin and dipyridamole on the degradation of adenosine diphosphate by cultured cells derived from bovine pulmonary artery.

Authors:  D J Crutchley; U S Ryan; J W Ryan
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

7.  Stimulation of endothelial prostacyclin production plays no role in endothelium-dependent relaxation of the pig aorta.

Authors:  J L Gordon; W Martin
Journal:  Br J Pharmacol       Date:  1983-09       Impact factor: 8.739

8.  Coronary vasoconstrictor and vasodilator actions of arachidonic acid in the isolated perfused heart of the rat.

Authors:  S E Belo; J Talesnik
Journal:  Br J Pharmacol       Date:  1982-02       Impact factor: 8.739

9.  The effect of prolonged treatment with sulphinpyrazone on thromboxane A2 and prostacyclin in man.

Authors:  L Viinikka; J Toivanen; O Ylikorkala
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

10.  The effect of acetylsalicylic acid (ASA) on the development of atherosclerotic lesions in miniature swine.

Authors:  P Clopath
Journal:  Br J Exp Pathol       Date:  1980-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.